查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1972091

毛细血管和静脉采血设备市场：按设备类型、技术、检体类型、采血部位、形态、年龄组、最终用户、应用和分销渠道划分——全球预测，2026-2032年

Capillary & Venous Blood Sampling Device Market by Device Type, Technology, Sample Type, Sample Site, Format, Age Group, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，毛细血管和静脉采血设备市场价值将达到 27.9 亿美元，到 2026 年将成长至 30.2 亿美元，到 2032 年将达到 49.8 亿美元，复合年增长率为 8.61%。

主要市场统计数据
基准年 2025 27.9亿美元
预计年份：2026年 30.2亿美元
预测年份：2032年 49.8亿美元
复合年增长率 (%) 8.61%

临床和技术环境的演变正在重塑医疗保健环境中采样设备的使用方式，并重新定义製造商和供应商的优先事项。

由于临床实践、监管要求和分销管道的同步发展，毛细血管和静脉采血设备市场正处于转型期。这些设备传统上仅限于检查室和医院静脉采血室，如今在更广泛的医疗服务中发挥核心作用，应用范围涵盖临床检测、照护现场诊断和家庭监测。随着临床团队将患者体验和营运效率置于优先地位，设备性能特征（例如检体完整性、易用性和与下游分析仪器的兼容性）已成为采购决策的首要考虑因素。

检测的快速分散化、对感染控制的日益重视以及法规的明确，正在推动设备设计和临床部署发生重大变化。

过去几年，变革性的变化彻底改变了医疗保健系统中血液采集设备的研发、采购和部署方式。随着诊断功能从临床环境转移到患者家中，人们对简单、耐用且易于使用的设备的需求日益增长。过去需要经过培训的血液采集技术人员操作的设备，如今正在重新设计，以便护士、看护者和患者本人都能使用，这使得血液采集流程更加註重直观的界面、清晰的操作说明和错误预防措施。

2025 年贸易政策的转变促使供应链进行大规模调整，重组了采购方式、采购重点和产品设计决策。

2025年实施的关税以及不断变化的贸易政策措施，已经改变了毛细血管和静脉采血设备製造商和经销商的供应链格局，对采购、产品设计和筹资策略等各个环节都产生了累积影响。依赖进口零件的製造商面临着不断上涨的到岸成本，被迫修改供应商合约和库存管理政策。为此，许多企业加快了供应商多元化进程，评估了近岸外包机会，并优先考虑双重采购安排，以降低关税波动带来的风险。

多维细分框架将仪器类型、最终用户、应用、技术、检体特征和分销管道连结起来，指南策略性产品类型和商业性优先顺序。

精细的細項分析揭示了每种设备类型、最终用户、应用、技术、检体类型、采集部位、形态、分销管道和患者年龄组的不同机会和风险。按设备类型划分，毛细管解决方案针对最小样本量进行了最佳化，而静脉系统则旨在获取多种分析物并进行大容量采集，两者之间存在着显着差异，各自需要独特的耗材和介面设计。按最终用户划分，诊所、诊断实验室、居家医疗和医院各自面临不同的营运限制。诊所必须在处理能力和患者体验之间取得平衡，并涵盖了普通诊所和专科诊所。检查室需要与医院或独立检查室的工作流程整合。居家医疗强调操作的便利性，无论是护士辅助的患者还是自我管理的患者。医院则涵盖了普通病房和专科病房，其手术复杂程度各不相同。

医疗服务模式、监管要求和供应链基础设施方面的区域差异，需要为每个地区量身定製商业策略。

区域趋势对需求集中地点、供应链建构方式以及临床应用案例的增加都有显着影响。在美洲，医疗保健系统重视能够部署于大规模医院网路和社区诊所的高度可扩展解决方案，尤其关注互通性、报销管道和检查室整合。此外，人们对居家检测方法的兴趣日益浓厚，并积极寻求伙伴关係，以便在不同的医疗保健环境中快速部署这些方法。

竞争对手正利用产品模组化、垂直整合和临床伙伴关係来确保采购交易并加强与客户的长期关係。

采样设备领域的主要企业正透过产品创新、供应链管理以及与诊断测试开发公司和临床网路建立策略合作伙伴关係来实现差异化竞争。市场领导正投资人体工学设计以减少使用者操作失误，并开发模组化平台以实现分析试剂盒和辅助耗材的快速安装。一些竞争对手正在寻求垂直整合，以确保关键耗材的供应，并减轻零件关税和物流限制的影响。

为製造商和买家提供切实可行的策略措施，以增强韧性、加速推广应用，并提高在各种临床管道中的商业性竞争力。

产业领导者应采取一系列协调一致的行动，以应对临床需求、日益严格的监管和供应链风险之间错综复杂的相互作用。首先，应优先考虑人性化的设计和经实践验证的易用性，以加快在护理人员辅助和自我监测环境中的部署，并确保标识和说明材料能够满足不同语言和识字水平的需求。其次，应建构具韧性的供应商网络，结合在地采购和策略性库存缓衝，以优化到岸成本，同时降低贸易政策的影响力。

本研究采用多面向方法，结合相关人员访谈、实际设备评估和二次检验，得出实用且经过严格检验的策略见解。

为确保研究结果的稳健性和相关性，本研究结合了实地研究、结构化的二手分析和质性检验。主要方法包括对医院、检查室、诊所和居家照护机构的临床相关人员进行详细访谈，以及与采购经理和供应链经理进行对话，以了解商业性因素。此外，也透过实际设备和人体工学评估，观察实际使用环境中的操作性和预分析工作流程，从而收集一手资讯。

综合研究结果表明，人性化的产品设计、稳健的采购和协作式商业化这三个要素紧密相连，是未来成功的关键。

总而言之，毛细血管和静脉采血设备的市场格局呈现出以下特点：检测流程的快速分散化、对易用性和安全性的期望不断提高，以及贸易伙伴关係导致的供应链复杂性。成功取决于产品设计能否与实际临床工作流程相契合、能否建立稳固的采购基础，以及能否在不同的医疗环境中展现其监管和营运价值。随着诊断工作流程不断从中心化检查室转移，那些投资于人性化的设计、策略合作和灵活商业化模式的公司，将更有利于实现长期市场认可。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：毛细血管和静脉采血设备市场：依设备类型划分

  • 微血管
  • 静脉

第九章：毛细血管和静脉采血设备市场：依技术划分

  • 自动的
  • 手动的
  • 照护现场

第十章：毛细血管和静脉采血装置市场：依检体类型划分

  • 电浆
  • 血清
  • 全血

第十一章 毛细血管和静脉采血装置市场：依采血部位划分

  • 指尖穿刺
  • 脚跟刺伤
  • 静脉穿刺

第十二章 毛细血管和静脉采血装置市场：依形式划分

  • 可重复使用的
  • 一次性

第十三章：毛细血管和静脉采血设备市场：依年龄组别划分

  • 成人
  • 老年人
  • 儿童

第十四章 毛细血管和静脉采血装置市场：依最终用户划分

  • 诊所
    • 一般诊所
    • 专科诊所
  • 诊断实验室
    • 医院检查室
    • 独立测试机构
  • 居家照护
    • 护理助理
    • 自我管理
  • 医院
    • 综合医院
    • 专科医院

第十五章：毛细血管和静脉采血装置市场：依应用划分

  • 用于诊断
    • 心臟检查
    • 糖尿病检测
  • 监测
    • 慢性病监测
    • 妊娠监测
  • 研究
    • 学术研究
    • 临床试验

第十六章：毛细血管和静脉采血设备市场：依通路划分

  • 直销
    • 企业客户的销售
    • 线上销售
  • 销售代理
    • 全国销售代理
    • 区域销售代理

第十七章 毛细血管及静脉采血设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十八章：毛细血管及静脉采血设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十九章 毛细血管和静脉采血装置市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第20章：美国毛细血管及静脉采血设备市场

第21章：中国毛细血管及静脉采血设备市场

第22章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Drawbridge Health, Inc.
  • Greiner Bio-One International GmbH
  • Nipro Corporation
  • Poly Medicure Limited
  • Radiometer Medical ApS
  • Roche Diagnostics International AG
  • Sarstedt AG & Co. KG
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-2B5802CFEB42

The Capillary & Venous Blood Sampling Device Market was valued at USD 2.79 billion in 2025 and is projected to grow to USD 3.02 billion in 2026, with a CAGR of 8.61%, reaching USD 4.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.79 billion
Estimated Year [2026] USD 3.02 billion
Forecast Year [2032] USD 4.98 billion
CAGR (%) 8.61%

An evolving clinical and technological environment is reshaping sampling device use across care settings and redefining priorities for manufacturers and providers

The capillary and venous blood sampling device landscape is at an inflection point driven by simultaneous advances in clinical practice, regulatory expectations, and channel evolution. Historically confined to laboratories and hospital phlebotomy suites, these devices are now central to a broader continuum of care that spans clinic-based testing, point-of-care diagnostics, and in-home monitoring. As clinical teams prioritize patient experience and operational efficiency, device performance characteristics such as sample integrity, ease of use, and compatibility with downstream analytics have risen to the forefront of procurement decisions.

Moreover, technological progress in microfluidics, automation, and integrated cartridge systems has expanded the functional envelope of sampling devices, enabling higher throughput and improved safety for both capillary and venous procedures. Simultaneously, healthcare systems are recalibrating workflows to support decentralized testing paradigms while preserving clinical quality controls and regulatory compliance. This dynamic environment demands that manufacturers, distributors, and healthcare providers re-evaluate product design, training, and supply chain strategies to sustain clinical reliability and drive adoption across diverse care settings.

Rapid decentralization of testing, heightened infection control priorities, and regulatory clarity are driving major shifts in device design and clinical adoption

In the past several years, transformative shifts have redefined how blood sampling devices are developed, procured, and deployed across health systems. The migration of diagnostic capabilities toward the point of care and patient homes has elevated requirements for device simplicity, robustness, and usability. Devices that once needed trained phlebotomists to operate are being reengineered for use by nursing staff, caregivers, and patients themselves, which in turn has increased emphasis on intuitive interfaces, clear instructions for use, and error-proofing of collection workflows.

Simultaneously, heightened infection control priorities and single-use preferences accelerated by public health events have influenced adoption patterns, prompting manufacturers to weigh the trade-offs between reusable systems and disposable formats. Advances in automation and sample processing have enabled integration with laboratory information systems, improving traceability and reducing pre-analytical errors. At the same time, regulatory agencies have signaled clearer expectations around device validation, stability data for different sample types such as plasma and serum, and human factors engineering. These combined shifts are catalyzing cross-industry collaboration between device makers, diagnostic developers, and clinical networks to deliver solutions that are both clinically rigorous and operationally scalable.

Trade policy shifts in 2025 prompted sweeping supply chain adaptations that reshaped sourcing practices, procurement priorities, and product design decisions

The imposition of tariffs and evolving trade policy measures in the United States during 2025 have altered supply chain calculus for manufacturers and distributors of capillary and venous blood sampling devices, with cumulative effects felt across procurement, product design, and sourcing strategies. Producers dependent on imported components confronted rising landed costs that required reassessment of supplier contracts and inventory policies. In response, many organizations accelerated supplier diversification, evaluated nearshoring opportunities, and prioritized dual-sourcing arrangements to reduce exposure to tariff volatility.

Buyers, particularly in institutional settings, began to reassess total cost of ownership rather than unit price alone, factoring in logistics overheads, customs delays, and the risk of intermittent supply shortages. For device developers, these pressures intensified incentives to redesign devices for lower-cost localizable components or to consolidate component suppliers to achieve economies of scale. At the distribution layer, margins compressed where tariff impacts could not be fully passed to end users, prompting renegotiations of commercial terms and selective withdrawal from low-margin segments.

Importantly, tariff-driven realignment also had indirect effects on innovation and market entry. New entrants and smaller suppliers faced higher barriers due to increased initial capital requirements and supply chain complexity, while established players with integrated manufacturing footprints leveraged scale to sustain competitive positioning. Overall, the cumulative tariff environment encouraged resilience planning across the value chain, prompting investments in domestic manufacturing capability, deeper supplier relationships, and more robust scenario-based procurement frameworks.

A multidimensional segmentation framework links device types, end users, applications, technologies, sample attributes, and channels to inform strategic product and commercial prioritization

A nuanced segmentation lens reveals differentiated opportunity and risk across device types, end users, applications, technologies, sample types, sample sites, formats, distribution channels, and patient age groups. When viewed by device type, the landscape bifurcates between capillary solutions optimized for minimal volume collection and venous systems designed for broader analyte access and higher volume requirements, each demanding unique consumable and interface design considerations. Across end users, clinics, diagnostic laboratories, home care, and hospitals present distinct operational constraints; clinics balance throughput with patient experience and include both general clinics and specialized clinics, laboratories require integration with hospital or independent lab workflows, home care emphasizes nurse-aided and self-monitoring usability, and hospitals incorporate both general and specialty units with varying procedure complexity.

Application-driven differentiation further refines market focus. Diagnostic use spans cardiac and diabetes testing, where pre-analytical stability and accurate sample handling are paramount; monitoring applications concentrate on chronic disease and pregnancy tracking that require repeatability and convenience; research activities subdivide into academic investigations and clinical trials with heightened regulatory and chain-of-custody demands. Technology choices-automated, manual, or point of care-directly impact training, capital investment, and integration needs. Sample type selection among plasma, serum, and whole blood influences processing workflows and downstream assay compatibility, while sample site considerations such as fingerstick, heel stick, and venipuncture determine device ergonomics and patient tolerability. Format options between reusable and single-use devices affect lifecycle costs, sterilization protocols, and sustainability assessments. Distribution channels split between direct sales and distributors, with direct sales differentiated by corporate and online channels and distributors ranging from national to regional partners, each channel carrying implications for service, support, and inventory management. Finally, age group segmentation across adult, geriatric, and pediatric cohorts introduces clinical and ergonomic requirements that shape device design, consumable sizing, and labeling practices. Taken together, these segmentation vectors provide a multidimensional framework for prioritizing product development, regulatory strategy, and commercial deployment.

Regional variations in care delivery models, regulatory expectations, and supply chain infrastructure demand tailored commercial strategies for each geography

Regional dynamics are materially influencing where demand concentrates, how supply chains are organized, and which clinical use cases gain traction. In the Americas, health systems emphasize scalable solutions that can be deployed across large hospital networks and community clinics, with particular attention to interoperability, reimbursement pathways, and laboratory integration. This region also shows accelerated interest in home-based testing modalities, and an appetite for partnerships that enable rapid deployment across diverse care settings.

In Europe, the Middle East, and Africa, regulatory harmonization efforts alongside diverse payer models create both opportunities and complexity for manufacturers. Buyers in this region often require stringent demonstrable compliance with local standards and value evidence that aligns with national health priorities. Distribution models vary widely across countries, necessitating adaptable channel strategies and localized service capabilities. In the Asia-Pacific region, growth is driven by a combination of rising healthcare access, investments in diagnostic infrastructure, and strong government-led initiatives to expand primary care capabilities. Local manufacturing hubs and a competitive supplier base contribute to cost-competitive sourcing, while varying clinical practices create demand for devices optimized to local sample types and settings. Collectively, these regional distinctions call for tailored commercial approaches that reconcile global product platforms with targeted local adaptations.

Competitors are leveraging product modularity, vertical integration, and clinical partnerships to secure procurement wins and strengthen long-term customer relationships

Leading companies in the sampling device ecosystem are differentiating through a mix of product innovation, supply chain control, and strategic partnerships with diagnostic test developers and clinical networks. Market leaders invest in human factors engineering to reduce user error and in modular platforms that enable rapid attachment of analytics cartridges or ancillary consumables. Several competitors have pursued vertical integration to secure critical consumables and mitigate the effects of component tariffs and logistics constraints.

Strategic partnerships with laboratory service providers and point-of-care diagnostic manufacturers have become a common route to accelerate adoption, as aligning sampling device design with end-to-end diagnostic workflows reduces friction at procurement and deployment. Service and maintenance capabilities also provide competitive advantage, especially in institutional channels where uptime and batch processing efficiency matter. Additionally, companies that offer robust training programs, digital support tools, and lifecycle management services tend to foster stronger long-term customer relationships. Finally, R&D focus areas among leading companies include enhanced sample stability, contamination control, and designs that reduce the need for cold chain logistics, all of which respond directly to operational pain points identified by clinical users.

Practical strategic moves for manufacturers and buyers to strengthen resilience, drive adoption, and improve commercial competitiveness across diverse clinical pathways

Industry leaders should adopt a coordinated set of actions to navigate the complex interplay of clinical demand, regulatory rigor, and supply chain risk. First, prioritize human-centered design and validated ease-of-use to accelerate adoption across nurse-aided and self-monitoring contexts, ensuring labeling and instructional materials address language and literacy diversity. Second, establish resilient supplier networks that combine local sourcing with strategic inventory buffers to reduce exposure to trade policy shocks while optimizing landed cost.

Third, align product roadmaps with key clinical use cases such as diabetes and cardiac diagnostic workflows, and invest in interoperability with laboratory information systems to simplify procurement conversations with institutional buyers. Fourth, pursue partnerships with diagnostic developers and clinical networks to co-develop integrated solutions that reduce friction at deployment and enhance clinical utility. Fifth, build a differentiated service offering that includes training, after-sales support, and lifecycle management to protect margins and strengthen customer loyalty. Sixth, incorporate sustainability considerations into product design by evaluating reusable versus disposable trade-offs and by optimizing packaging to reduce logistics weight and waste. Finally, enhance regulatory and quality functions to accelerate approvals across diverse jurisdictions and to generate the real-world evidence needed to support payer engagement and clinical adoption.

A multi-method research design combined stakeholder interviews, hands-on device evaluations, and secondary validation to produce actionable and rigorously validated strategic insights

The research underpinning these insights combined primary fieldwork with structured secondary analysis and qualitative validation to ensure robustness and relevance. Primary methods included in-depth interviews with clinical stakeholders across hospital, laboratory, clinic, and home care settings, complemented by conversations with procurement leaders and supply chain managers to understand commercial drivers. Additional primary inputs were obtained from hands-on device evaluations and human factors assessments to observe real-world usability and pre-analytical workflows.

Secondary research surveyed regulatory guidance documents, standards for sample handling and device validation, and publicly available technical literature on automation and microfluidic approaches. Data triangulation occurred through cross-referencing interview findings with technical specifications, regulatory filings, and device labeling to identify consistent themes and validate observed trends. Finally, scenario analysis and expert panel review refined interpretations around trade policy impacts and regional differentiation, enabling the translation of qualitative evidence into actionable insights for product, supply chain, and go-to-market strategies.

Consolidating research insights points to the critical nexus of human-centered product design, resilient sourcing, and collaborative commercialization as keys to future success

In summary, the capillary and venous blood sampling device landscape is characterized by rapid decentralization of testing, heightened expectations for usability and safety, and intensified supply chain complexity driven by trade dynamics. Success will hinge on a company's ability to harmonize product design with real-world clinical workflows, secure resilient sourcing, and demonstrate regulatory and operational value across diverse care settings. Those who invest in human-centered design, strategic partnerships, and flexible commercialization models will be best positioned to capture long-term adoption as diagnostic workflows continue to migrate beyond centralized laboratories.

Looking forward, leaders must balance near-term operational resilience with long-term innovation that embraces automation, integration, and sustainability. By doing so, they can deliver clinically robust sampling solutions that meet the evolving needs of patients, providers, and payers while maintaining commercial agility amid shifting policy and regional dynamics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Capillary & Venous Blood Sampling Device Market, by Device Type

  • 8.1. Capillary
  • 8.2. Venous

9. Capillary & Venous Blood Sampling Device Market, by Technology

  • 9.1. Automated
  • 9.2. Manual
  • 9.3. Point Of Care

10. Capillary & Venous Blood Sampling Device Market, by Sample Type

  • 10.1. Plasma
  • 10.2. Serum
  • 10.3. Whole Blood

11. Capillary & Venous Blood Sampling Device Market, by Sample Site

  • 11.1. Fingerstick
  • 11.2. Heel Stick
  • 11.3. Venipuncture

12. Capillary & Venous Blood Sampling Device Market, by Format

  • 12.1. Reusable
  • 12.2. Single Use

13. Capillary & Venous Blood Sampling Device Market, by Age Group

  • 13.1. Adult
  • 13.2. Geriatric
  • 13.3. Pediatric

14. Capillary & Venous Blood Sampling Device Market, by End User

  • 14.1. Clinic
    • 14.1.1. General Clinic
    • 14.1.2. Specialized Clinic
  • 14.2. Diagnostic Laboratory
    • 14.2.1. Hospital Laboratory
    • 14.2.2. Independent Laboratory
  • 14.3. Home Care
    • 14.3.1. Nurse Aided
    • 14.3.2. Self Monitoring
  • 14.4. Hospital
    • 14.4.1. General Hospital
    • 14.4.2. Specialty Hospital

15. Capillary & Venous Blood Sampling Device Market, by Application

  • 15.1. Diagnostic
    • 15.1.1. Cardiac Testing
    • 15.1.2. Diabetes Testing
  • 15.2. Monitoring
    • 15.2.1. Chronic Disease Monitoring
    • 15.2.2. Pregnancy Monitoring
  • 15.3. Research
    • 15.3.1. Academic Research
    • 15.3.2. Clinical Trials

16. Capillary & Venous Blood Sampling Device Market, by Distribution Channel

  • 16.1. Direct Sales
    • 16.1.1. Corporate Sales
    • 16.1.2. Online Sales
  • 16.2. Distributors
    • 16.2.1. National Distributor
    • 16.2.2. Regional Distributor

17. Capillary & Venous Blood Sampling Device Market, by Region

  • 17.1. Americas
    • 17.1.1. North America
    • 17.1.2. Latin America
  • 17.2. Europe, Middle East & Africa
    • 17.2.1. Europe
    • 17.2.2. Middle East
    • 17.2.3. Africa
  • 17.3. Asia-Pacific

18. Capillary & Venous Blood Sampling Device Market, by Group

  • 18.1. ASEAN
  • 18.2. GCC
  • 18.3. European Union
  • 18.4. BRICS
  • 18.5. G7
  • 18.6. NATO

19. Capillary & Venous Blood Sampling Device Market, by Country

  • 19.1. United States
  • 19.2. Canada
  • 19.3. Mexico
  • 19.4. Brazil
  • 19.5. United Kingdom
  • 19.6. Germany
  • 19.7. France
  • 19.8. Russia
  • 19.9. Italy
  • 19.10. Spain
  • 19.11. China
  • 19.12. India
  • 19.13. Japan
  • 19.14. Australia
  • 19.15. South Korea

20. United States Capillary & Venous Blood Sampling Device Market

21. China Capillary & Venous Blood Sampling Device Market

22. Competitive Landscape

  • 22.1. Market Concentration Analysis, 2025
    • 22.1.1. Concentration Ratio (CR)
    • 22.1.2. Herfindahl Hirschman Index (HHI)
  • 22.2. Recent Developments & Impact Analysis, 2025
  • 22.3. Product Portfolio Analysis, 2025
  • 22.4. Benchmarking Analysis, 2025
  • 22.5. 3M Company
  • 22.6. Becton, Dickinson and Company
  • 22.7. Bio-Rad Laboratories, Inc.
  • 22.8. Danaher Corporation
  • 22.9. Drawbridge Health, Inc.
  • 22.10. Greiner Bio-One International GmbH
  • 22.11. Nipro Corporation
  • 22.12. Poly Medicure Limited
  • 22.13. Radiometer Medical ApS
  • 22.14. Roche Diagnostics International AG
  • 22.15. Sarstedt AG & Co. KG
  • 22.16. Terumo Corporation
  • 22.17. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 15. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. UNITED STATES CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 17. CHINA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CAPILLARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CAPILLARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CAPILLARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FINGERSTICK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FINGERSTICK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FINGERSTICK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HEEL STICK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HEEL STICK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HEEL STICK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENIPUNCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENIPUNCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY VENIPUNCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALIZED CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALIZED CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALIZED CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY INDEPENDENT LABORATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY INDEPENDENT LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY INDEPENDENT LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NURSE AIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NURSE AIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NURSE AIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SELF MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SELF MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SELF MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY GENERAL HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALTY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALTY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SPECIALTY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CARDIAC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CARDIAC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CARDIAC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIABETES TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIABETES TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIABETES TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CHRONIC DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PREGNANCY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PREGNANCY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY PREGNANCY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CORPORATE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CORPORATE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CORPORATE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY NATIONAL DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REGIONAL DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORY, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY SAMPLE SITE, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY FORMAT, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVICE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA CAPILLARY & VENOUS BLOOD SAMPLING DEVI